Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Morrell

Showing results (11-20 of 278) with videos related to

Pageof 28
Sort By:
Current Hypertension Reports|October 1, 2013
Genetics and the molecular pathogenesis of pulmonary arterial hypertensionDong Liu, Nicholas W Morrell
The Lancet. Respiratory Medicine|January 15, 2017
Pulmonary veno-occlusive disease: characterising a rare but important diseaseCharaka Hadinnapola, Nicholas W Morrell
The European Respiratory Journal|October 4, 2016
Towards a molecular classification of pulmonary arterial hypertensionStefan Gräf, Nicholas W Morrell
Expert Review of Respiratory Medicine|April 23, 2011
New frontiers in pulmonary hypertensionLewis J Rubin, Nicholas W Morrell
Experimental Physiology|May 7, 2013
The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and diseasePaul D Upton, Nicholas W Morrell
Clinical Medicine (London, England)|July 11, 2002
Flexibility and diversity in consultant careersNicholas W Morrell, Carol M Black
Circulation|October 10, 2012
Understanding the low penetrance of bone morphogenetic protein receptor 2 gene mutations: another needle in the haystackR James White, Nicholas W Morrell
American Journal of Respiratory and Critical Care Medicine|November 3, 2012
Waiting in anticipation: the genetics of pulmonary arterial hypertensionMicheala A Aldred, Nicholas W Morrell
Chest|December 9, 2008
Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptorRachel J Davies, Nicholas W Morrell
Current Opinion in Pharmacology|March 27, 2009
TGF-beta and BMPR-II pharmacology--implications for pulmonary vascular diseasesPaul D Upton, Nicholas W Morrell
Pageof 28

Showing results (11-20 of 278) with videos related to

Sort By:
Pageof 28
Current Hypertension Reports|October 1, 2013
Genetics and the molecular pathogenesis of pulmonary arterial hypertensionDong Liu, Nicholas W Morrell
The Lancet. Respiratory Medicine|January 15, 2017
Pulmonary veno-occlusive disease: characterising a rare but important diseaseCharaka Hadinnapola, Nicholas W Morrell
The European Respiratory Journal|October 4, 2016
Towards a molecular classification of pulmonary arterial hypertensionStefan Gräf, Nicholas W Morrell
Expert Review of Respiratory Medicine|April 23, 2011
New frontiers in pulmonary hypertensionLewis J Rubin, Nicholas W Morrell
Experimental Physiology|May 7, 2013
The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and diseasePaul D Upton, Nicholas W Morrell
Clinical Medicine (London, England)|July 11, 2002
Flexibility and diversity in consultant careersNicholas W Morrell, Carol M Black
Circulation|October 10, 2012
Understanding the low penetrance of bone morphogenetic protein receptor 2 gene mutations: another needle in the haystackR James White, Nicholas W Morrell
American Journal of Respiratory and Critical Care Medicine|November 3, 2012
Waiting in anticipation: the genetics of pulmonary arterial hypertensionMicheala A Aldred, Nicholas W Morrell
Chest|December 9, 2008
Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptorRachel J Davies, Nicholas W Morrell
Current Opinion in Pharmacology|March 27, 2009
TGF-beta and BMPR-II pharmacology--implications for pulmonary vascular diseasesPaul D Upton, Nicholas W Morrell
Pageof 28